Abstract
Fluconazole is a novel, systemically administered triazole antifungal agent, used primarily in the treatment of mucosal and systemic Candida infections and cryptococcosisl.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
E.Tümbay, Sistematik etkili yeni bir antifungal kemoterapötik: Flukonazal (Fluconazole: a novel antifungal chemotherapeutic with systemic effect), İnfeks. Derg. 3 (1), Ek Baski Seri No 1 (Suppl. 1) 27 pp. (1989).
K.W.Brammer and M.H. Tarbit, A review of the pharmakokinetics of fluconazole (UK-49,858) in laboratory animals and man, in: “Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents”, R.A. Fromtling, ed., pp. 141–150, Prous Science Publishers, Barcelona (1987).
P.R. Farrow, J.K.Faulkner, K.W.Brammer, The pharmacokinetics of fluconazole, in “Fluconazole Symposium Abstracts, 8–9 October 1988, Dorado, Puerto Rico”, p. 18 (1988).
R.A.Fromtling: Overview of medically important antifungal azole derivatives, Clin. Microbiol.Rev., 1: 187 (1988).
K.W.Brammer, Fluconazole: Profile of a new systemically-effective azole antifungal, in “Abstracts of Biennial Conference on Chemotherapy of Infectious Diseases and Malignancies, 5–8 March 1989, Montreux, Switzerland”, Abstract No 73, Zbl. Antimikrob.Antineoplas.Chemother., Suppl 1 (1989).
W.E. Dismukes, Azole antifungal drugs: Old and new, Ann. Intern. Med., 109: 177 (1988).
G.Foulds, C.Brennan, D.J.Weidler, D.C.Garg, P.Gibson, Steady state parenteral kinetics of fluconazole in man, in:“Abstracts of the First International Conference on Drug Research in Immunologic and Infectious Diseases. Antifungal Synthesis, Preclinical Evaluation, October 1987, New York” (1987).
P.F.Troke, R.J.Andrews, G.W.Pye, K.Richardson, Fluconazole and other azoles: Translation of in vitro activity to in vivo and clinical efficacy, in: “Fluconazole Symposium Abstracts, 5–9 October 1988, Dorado, Puerto Rico”, p. 7 (1988).
P.F.Troke, R.I.Andrews, K.W.Brammer, M.S.Marriott, K.Richardson, Efficacy of UK-49,858 (Fluconazole) against Candida albicans experimental infection in mice, Antimicrob. Agents Chemother. 28: 815 (1985).
K.W.Brammer and J.M.Feczko, Oral fluconazole in the treatment of acute vaginal candidiasis - A review of the phase III clinical program in: “Fluconazole Symposium Abstracts, 8–9 October 1988, Dorado, Puerto Rico” p. 21 (1988).
K.W.Brammer and L.J.Lees, Single dose of oral fluconazole in the treatment of vulvovaginal candidosis: An interim analysis of comparative study versus three-day intra-vaginal clotrimazole tablets, in: “Recent Trends in the Discovery, Development and Evaluation of Antifungal Agents”, R.A. Fromtling, ed., pp.151156, Barcelona, Prous Science Publishers, Barcelona (1987).
K.W.Brammer et al (Multicenter Study Group), Treatment of vaginal candidiasis with a single dose of fluconazole, Eur. J. Clin. Microhiol., 7: 364 (1988).
A.Lassus, E.Kaappa, T.Virrankoski, A.Eskelinen, An open study to compare efficacy, safety, and toleration of a single dose of fluconazole (UK-49,858) and clotrimazole intravaginal tablets given once daily for 3 days in the treatment of patients with vaginal candidosis, in: “Abstracts of the Second World Congress for Sexually Transmitted Diseases, June 1986, Paris” (1986).
E.Tümbay “Pratik Tip Mikolojisi (Practical Medical Mycology)” Bilgehan Basimevi, Izmir (1983).
E.Tümbay, K.Soy, G.Gürel, Bir çiftte saptanan genital kandidozun flukonazol ile sa altimi (Fluconazole treatment of genital candidosis in sexual partners), Tnfeks. Derg. 3: 265 (1989).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Plenum Press, New York
About this chapter
Cite this chapter
Tümbay, E. et al. (1991). Single-Dose Fluconazole Treatment of Vaginal Candidosis. In: Tümbay, E., Seeliger, H.P.R., Anǧ, Ö. (eds) Candida and Candidamycosis. Federation of European Microbiological Societies Symposium Series, vol 50. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5910-4_49
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5910-4_49
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5912-8
Online ISBN: 978-1-4684-5910-4
eBook Packages: Springer Book Archive